109 related articles for article (PubMed ID: 571042)
1. Plenary lecture: lymphocytic infiltration in relationship to urologic tumors.
Mostofi FK; Sesterhenn I
Natl Cancer Inst Monogr; 1978 Dec; (49):133-41. PubMed ID: 571042
[TBL] [Abstract][Full Text] [Related]
2. Immunologic features of genitourinary cancer.
Javadpour N
Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
[No Abstract] [Full Text] [Related]
3. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
[No Abstract] [Full Text] [Related]
4. Carcinoembryonic antigen in patients with tumors of the urogenital tract.
Reynoso G; Chu TM; Guinan P; Murphy GP
Cancer; 1972 Jul; 30(1):1-4. PubMed ID: 5064805
[No Abstract] [Full Text] [Related]
5. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
[No Abstract] [Full Text] [Related]
6. Binding of human IgG to cultured urogenital tumor cells.
Wright GL; Beckett ML; Campbell AE; Gardner KG; Somers KD
J Natl Cancer Inst; 1987 Jun; 78(6):1061-8. PubMed ID: 3473247
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
[TBL] [Abstract][Full Text] [Related]
8. [Degree of lymphocytic infiltration of the epithelium in bladder tumors].
Sapritskiĭ AV; Panchenko KI
Vopr Onkol; 1983; 29(7):66-71. PubMed ID: 6880136
[TBL] [Abstract][Full Text] [Related]
9. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
Rost A; Kneppenberg U; Rost P
Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
11. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
Hakala TR
Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
13. [6 cases of second primary neoplasms].
Ardiles A; Aldunate C; Lagos M; Larraín P; Martínez C; Olivares R
Rev Med Chil; 1990 Nov; 118(11):1291-3. PubMed ID: 1967110
[No Abstract] [Full Text] [Related]
14. Prognostic value of host immunocompetence in urologic cancer patients.
Catalona WJ; Smolev JK; Harty JI
J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
[TBL] [Abstract][Full Text] [Related]
15. [The significance of lymphocytic infiltration in urologic tumors: studies of distributions of B and T-lymphocytes and its subsets, and functional analysis of the infiltrating lymphocytes (author's transl)].
Akaza H
Nihon Hinyokika Gakkai Zasshi; 1981 Jan; 72(1):86-97. PubMed ID: 6974272
[No Abstract] [Full Text] [Related]
16. Immunological evaluation in patients with urological cancers.
Martinez-Piñeiro JA; Muntanola P; Hidalgo L
Eur Urol; 1977; 3(3):159-62. PubMed ID: 560302
[TBL] [Abstract][Full Text] [Related]
17. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
Hering H; Hering FJ; Weidner W
Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
[TBL] [Abstract][Full Text] [Related]
18. Correlation of primary tumor bed lymphocytic infiltration and peripheral lymphocyte cytotoxicity in patients with transitional cell carcinoma.
Jones LW; O'Toole C
Natl Cancer Inst Monogr; 1978 Dec; (49):183-5. PubMed ID: 748770
[TBL] [Abstract][Full Text] [Related]
19. Concanavalin A-activated suppressor cell activity in peripheral blood lymphocytes of urologic cancer patients.
Catalona WJ; Ratliff TL; McCool RE
J Natl Cancer Inst; 1980 Sep; 65(3):553-7. PubMed ID: 6157855
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]